Monovalent XBB.1.5 Provides Protection Against XBB And JN Lineage Hospitalization, Results Show

September 16, 2024

Infectious Disease Advisor (9/13, Basilio) reported, “Monovalent XBB.1.5, the updated COVID-19 vaccine for the 2023 to 2024 season, provides protection against XBB and JN lineage hospitalization,” study results show. However, immune escape may attenuate “protection against the JN lineage, according to” the findings published in Clinical Infectious Diseases.